| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 03/08/2001 | WO2001016319A2 Compositions and methods for the treatment of immune related diseases |
| 03/08/2001 | WO2001016299A1 Use of dna encoding osteoprotegerin to prevent or inhibit metabolic bone disorders |
| 03/08/2001 | WO2001016180A2 Cd40 agonist compositions and methods of use |
| 03/08/2001 | WO2001016170A2 Card proteins involved in cell death regulation |
| 03/08/2001 | WO2001016156A1 Attractin-like polynucleotides, polypeptides, and antibodies |
| 03/08/2001 | WO2001016139A1 Androgen receptor modulator compounds and methods |
| 03/08/2001 | WO2001016138A1 Sulfonylphenylpyrazole compounds useful as cox-2 inhibitors |
| 03/08/2001 | WO2001016137A1 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
| 03/08/2001 | WO2001016135A2 Reverse-turn mimetics and methods relating thereto |
| 03/08/2001 | WO2001016134A1 Selective antagonists of a2b adenosine receptors |
| 03/08/2001 | WO2001016127A1 Chromone derivatives, process for the preparation of the same and uses thereof |
| 03/08/2001 | WO2001016123A1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of inflammation |
| 03/08/2001 | WO2001016122A1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes |
| 03/08/2001 | WO2001016114A2 Heterocyclic compounds and methods for modulating cxcr3 function |
| 03/08/2001 | WO2001016097A1 Phosphate mimics and methods of treatment using phosphatase inhibitors |
| 03/08/2001 | WO2001015752A1 Phospholipid-coated implants |
| 03/08/2001 | WO2001015732A1 Remedies for immunological diseases |
| 03/08/2001 | WO2001015720A1 Methods and compositions for reducing serum phosphate levels |
| 03/08/2001 | WO2001015715A2 Composition for maintenance of bone or dental health or treatment of bone or dental disorders |
| 03/08/2001 | WO2001015707A1 Uses of diterpenoid triepoxides as an anti-proliferative agent |
| 03/08/2001 | WO2001015664A2 Coformulation methods and their products |
| 03/08/2001 | WO2001015553A1 Dietary food supplement containing natural cyclooxygenase inhibitors |
| 03/08/2001 | WO2001015531A1 Methods of and compositions for inhibiting the proliferation of mammalian cells |
| 03/08/2001 | WO2000059506A8 HETEROCYCLIC CONTAINING BIPHENYL aP2 INHIBITORS AND METHOD |
| 03/08/2001 | WO2000059448A3 Association of no-synthase inhibitor(s) and metabolic antioxidant(s) |
| 03/08/2001 | WO2000054762A3 Use of cross linked polysaccharides for the inhibition of angiogenesis |
| 03/08/2001 | WO2000050872A3 A system for cell-based screening |
| 03/08/2001 | WO2000020447A8 Polynucleotides coding for secreted polypeptides, some having similarity to syncollin or claudin or cytokine, their therapeutic uses |
| 03/08/2001 | WO1999065449A8 INHIBITORS OF TRANSCRIPTION FACTOR NF-λB |
| 03/08/2001 | WO1999019296A8 Aminobutanoic acid derivatives |
| 03/08/2001 | CA2419618A1 Phospholipid-coated implants |
| 03/08/2001 | CA2384194A1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of inflammation |
| 03/08/2001 | CA2384126A1 Reverse-turn mimetics and methods relating thereto |
| 03/08/2001 | CA2384055A1 Compositions and methods for the treatment of immune related diseases |
| 03/08/2001 | CA2383693A1 Card proteins involved in cell death regulation |
| 03/08/2001 | CA2383347A1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes |
| 03/08/2001 | CA2383077A1 Androgen receptor modulator compounds and methods |
| 03/08/2001 | CA2383043A1 Use of dna encoding osteoprotegerin to prevent or inhibit metabolic bone disorders |
| 03/08/2001 | CA2382789A1 Phosphate mimics and methods of treatment using phosphatase inhibitors |
| 03/08/2001 | CA2382556A1 Coformulation methods and their products |
| 03/08/2001 | CA2382427A1 Uses of diterpenoid triepoxides as an anti-proliferative agent |
| 03/08/2001 | CA2382303A1 Methods of and compositions for inhibiting the proliferation of mammalian cells |
| 03/08/2001 | CA2381713A1 Methods and compositions for reducing serum phosphate levels |
| 03/08/2001 | CA2381451A1 Attractin-like polynucleotides, polypeptides, and antibodies |
| 03/08/2001 | CA2380355A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/08/2001 | CA2379421A1 Sulfonylphenylpyrazole compounds useful as cox-2 inhibitors |
| 03/08/2001 | CA2308049A1 Diagnostic and therapeutic methods in autoimmune disease |
| 03/07/2001 | EP1081146A1 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| 03/07/2001 | EP1081137A1 Selective inhibitors of aggrecanase in osteoarthritis treatment |
| 03/07/2001 | EP1081132A1 Hydroxamic acid derivatives and medicinal utilization thereof |
| 03/07/2001 | EP1080194A2 Human transmembrane proteins |
| 03/07/2001 | EP1080180A2 Secreted proteins and polynucleotides encoding them |
| 03/07/2001 | EP1080095A1 Modulators of protein tyrosine phosphatases (ptpases) |
| 03/07/2001 | EP1080087A1 Novel 2-alkyl substituted imidazole compounds |
| 03/07/2001 | EP1080078A1 Heterocyclic compounds and methods to treat cardiac failure and other disorders |
| 03/07/2001 | EP1080073A1 Compositions comprising 2-phenyl-indole compounds and estrogen formulations |
| 03/07/2001 | EP1080068A1 Modulators of protein tyrosine phosphatases |
| 03/07/2001 | EP1080055A2 24-hydroxyvitamin d, analogs and uses thereof |
| 03/07/2001 | EP1079863A1 Use of a cox-2 inhibitor and a nk-1 receptor antagonist for treating inflammation |
| 03/07/2001 | EP1079852A1 Composition based on pentoxifylline and anticytokin |
| 03/07/2001 | EP1079848A1 Angiostatin receptor |
| 03/07/2001 | EP1079847A2 Osteoporosis treatment |
| 03/07/2001 | EP1079825A2 Compounds that inhibit the binding of integrins to their receptors |
| 03/07/2001 | EP1079821A1 Protease inhibitors |
| 03/07/2001 | EP1079803A2 Protein formulations |
| 03/07/2001 | CN1286694A Novel 19-norsteroids substd in position 11 'beta', preparation method and intermediates, application as medicines and pharmaceutical compositions contg. them |
| 03/07/2001 | CN1286258A Purine L-nucleoside, analogs and use thereof |
| 03/07/2001 | CN1286114A Ointment for quickly setting up bones |
| 03/07/2001 | CN1286113A Medical capsule for treating rheumatism and building up body and its preparing process |
| 03/07/2001 | CN1286102A 'Wanpitong' capsule for treating numbness |
| 03/07/2001 | CN1286094A Medicine for accelerating union of bone fracture |
| 03/07/2001 | CN1286088A Instant aminoacid-calcium particles and preparing process thereof |
| 03/07/2001 | CN1062908C Polypeptides and DNAs encoding them |
| 03/07/2001 | CN1062768C Medicine for treating rheumatism diseases |
| 03/07/2001 | CN1062747C Bone-setting medicine and preparing method thereof |
| 03/06/2001 | US6197982 Vitamin D analogues |
| 03/06/2001 | US6197826 α-(2-hydroxyphenyl) nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation |
| 03/06/2001 | US6197824 Benzamidine derivatives and the use thereof as medicaments with LTB4-antagonistic effect |
| 03/06/2001 | US6197811 Synthetic derivatives of phomalactone, a known compound obtainable by fermentation of the fungus phomopsis sp, have activity as inhibitors of cytokine production in treatment of disorders requiring immunosuppression, for example |
| 03/06/2001 | US6197810 3-(arylsulfonylamino)-tetrahydropyran-3-carboxylic acid hydroxamides |
| 03/06/2001 | US6197785 Cardiovascular disorders |
| 03/06/2001 | US6197776 Method for treatment of reactive arthritis or bursitis |
| 03/06/2001 | US6197770 Alkenyl- and alkynl-containing metalloprotease inhibitors |
| 03/06/2001 | US6197759 Osteoblast-specific mitogens and drugs containing such compounds |
| 03/06/2001 | US6197294 Cells containing recombinant polynucleotides coding for cell surface molecules that, when expressed in the cell, result in rejection of the cell by host cell by host immune system; useful for gene therapy |
| 03/06/2001 | US6197069 Adrenomedullin receptor polynucleotides |
| 03/01/2001 | WO2001014886A2 Inhibitors of binding between proteins and macromolecular ligands |
| 03/01/2001 | WO2001014557A1 Pd-1, a receptor for b7-4, and uses therefor |
| 03/01/2001 | WO2001014548A2 New g-protein coupled receptor and dna sequences thereof |
| 03/01/2001 | WO2001014415A2 Egfh2 genes and gene products |
| 03/01/2001 | WO2001014405A2 Methods of obtaining 2-methoxyestradiol of high purity |
| 03/01/2001 | WO2001014375A1 Imidazo[1,2-a]pyridine and pyrazolo[2,3-a]pyridine derivatives |
| 03/01/2001 | WO2001014371A1 N-heterocyclic derivatives as nos inhibitors |
| 03/01/2001 | WO2001014358A2 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benozopyrans |
| 03/01/2001 | WO2001014353A1 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 03/01/2001 | WO2001014342A1 Aminocarbonyl-substituted benzimidazole derivatives, method for producing same and the use thereof as medicaments |
| 03/01/2001 | WO2001014338A1 NOVEL INTEGRIN αVβ3 INHIBITORS |
| 03/01/2001 | WO2001014337A1 αvβ3 INTEGRIN INHIBITORS |
| 03/01/2001 | WO2001014333A1 Substituted piperidine compounds useful as modulators of chemokine receptor activity |
| 03/01/2001 | WO2001014320A1 Compounds that inhibit tryptase activity |